VibroSense Dynamics AB has received a European patent on a principle that measures skin temperature automatically and wirelessly, before and during an examination, which ensures measurement quality. The patent is a so-called European patent (Unitary Patent) which has been extended by two additional countries.
A Unitary Patent in the EU provides protection in Austria, Belgium, Bulgaria, Denmark, Estonia, Finland, France, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Portugal, Romania, Slovenia, Sweden and Germany. In addition to these countries, the patent has also been approved and registered in the United Kingdom and Spain.
"Our product VibroSense Meter II has now received protection in almost the entire EU, which is part of the company's strategy to secure the product's IP. The highest level consists of patents and designs with the aim of preventing infringement of essential functions for the instrument's measurement principle. In addition to patents, the product is also protected with encrypted algorithms in the software and by exclusive access rights to extensive clinical data. The patent on continuous temperature measurement further strengthens the protection of our product," says Toni Speidel, CTO VibroSense Dynamics AB.
Contact
Toni Speidel, CTO VibroSense Dynamics AB
Tel: +46 40 88 026
Email: info@vibrosense.com
www.vibrosense.com
“The new Gold Standard for reliable
detection of nerve damage”
About VibroSense Dynamics AB (pub)
VibroSense Dynamics AB (publ) develops and sells medical devices and services for diagnostic support in nerve damage in the hands and feet. The method is based on measuring and quantifying the ability to feel vibrations at multiple frequencies. The company's customers are diabetes clinics, occupational health care, hospitals, point of care centers and researchers.
Our vision is for the company's products to be a standard instrument in all neurological examinations to detect early signs of changes in sensation so that patients and their caregivers can take preventive measures that prevent, reduce or delay the onset of nerve damage in the hands and feet.